small molecule

BAROS

SODIUM BICARBONATE; TARTARIC ACID

Loss of exclusivityloss of exclusivity
CompanyMALLINCKRODT INC

Drug detail

Brand nameBAROS
Active ingredientSODIUM BICARBONATE; TARTARIC ACID
Strength460MG/GM;420MG/GM
Dosage formGRANULE, EFFERVESCENT
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1985
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BAROS patent cliff — loss of exclusivity — | CliffBio